H&O March 2011 :: Our Publications :: Millennium Medical Publishing

Doctor reading.

Featured Sponsor

Featured Sponsor

More Reading

Find what you're looking for by browsing or searching our online archives.

Browse by Category:

Search by keyword:

Our Publications

Clinical Advances in Hematology & Oncology
Editorial Advisory Board
Media Kit
PDF Download
Author Guidelines
Copyright and Disclaimer
Indexed by the National Library of Medicine and EMBASE.

H&O March 2011

March 2011

Volume 9, Issue 3

Features

Feature Article: Bisphosphonates in Breast Cancer: Clinical Activity and Implications of Preclinical Data: Rebecca Aft, MD, PhD; Categories: Breast

Feature Article: A Phase I Study of Panobinostat in Combination With Gemcitabine in the Treatment of Solid Tumors: Suzanne F. Jones, PharmD, Johanna C. Bendell, MD, Jeffrey R. Infante, MD, David R. Spigel, MD, Dana S. Thompson, MD, Denise A. Yardley, MD, F. Anthony Greco, MD, Patrick B. Murphy, MD, and Howard A. Burris, III, MD; Categories: Solid Tumor Malignancies

Feature Article: New Targets in Advanced NSCLC: EML4-ALK: Adam S. Crystal, MD, PhD, and Alice T. Shaw, MD, PhD; Categories: Lung, Targeted Therapy

Clinical Case Study: A Cirrhotic Patient With Spontaneous Intramuscular Hematoma Due to Primary Hyperfibrinolysis: Girish B. Nair, MD, Mahamood Lajin, MD, and Alaa Muslimani, MD; Categories: Hematology, Liver

Clinical Case Review: Primary Hyperfibrinolysis in Liver Disease: A Critical Review: Nabila Bennani-Baiti, MD, and Hamed A. Daw, MD; Categories: Hematology, Liver

Clinical Case Study: Survival More Than 19 Years After the Diagnosis of Accelerated Phase of Chronic Myelocytic Leukemia: Peter H. Wiernik, MD, Mahadi A. Baig, MD, Sung H. Lee, MD, Janice P. Dutcher, MD, Elisabeth Paietta, PhD, and Janis Racevskis, PhD; Categories: Leukemia

Clinical Case Review: CML: A Model Disease With a Defined Oncogenic Driver: Zhonglin Hao, MD, PhD, and John K. Cowell, PhD, DSc, FRCPath; Categories: Leukemia

Columns

Advances in LLM: Lenalidomide in CLL: What Is the Optimal Dose?: Clemens M. Wendtner, MD; Categories: Leukemia, LLM

Advances in Oncology: Breast Cancer In Focus: Nontaxane Microtubule Dynamics Inhibitors: Javier Cortes, MD; Categories: Breast, Oncology

Advances in Hematology: Autoimmune Lymphoproliferative Syndrome: New Approaches to Diagnosis and Management: David T. Teachey, MD; Categories: Hematology

Advances in Drug Development: Current Dilemmas in Carboplatin Dosing: Mark J. Ratain, MD; Categories: Drug Development

Hem/Onc News: Recent Clinical Findings: Stacey Small; Categories: Breast, Head and Neck, Lymphoma, Squamous Cell Carcinoma

Letter From the Editor: Bruce D. Cheson, MD; Categories: Letter From the Editor

CMExpress Opportunities

Presentations Review: Recent Advances in the Treatment of Multiple Myeloma: Sundar Jagannath, MD